Mixture-Design Optimization of an Intranasal Self-Nanoemulsifying Drug Delivery System Co-Loaded with Olmesartan Medoxomil and Apigenin: Composition Modeling and Ex Vivo Nasal Permeation
Year: 2026
Type: article
Abstract: Background/Objectives: Ischemic brain injury involves parallel oxidative, inflammatory, and vascular cascades. Olmesartan medoxomil and apigenin act on complementary arms and can serve this purpose. This study developed a self-nanoemulsifying drug delivery system (SNEDDS) co-loaded with both agents for intranasal use. Constrained mixture design was used to determine its actual composition. Methods: Oil and cosolvent were selected by saturation solubility and surfactant by emulsification transmittance. The proportions of Kolliphor EL (40–70% w/w), poly(ethylene glycol) 400 (5–30% w/w), and Imwitor 308 (20–40% w/w) were treated as mixture variables and each drug’s solubility as the response. Desirability analysis identified the optimum composition, which was experimentally verified. After that, it was compared with a drug suspension for permeation across excised goat nasal mucosa in Franz diffusion cells. Results: Apigenin solubility followed a linear mixture model and olmesartan medoxomil a quadratic model. The optimum composition (52.33% Kolliphor EL, 27.67% poly(ethylene glycol) 400, 20.00% Imwitor 308) gave observed solubilities of 11.82 and 6.91 mg/g, within the 95% prediction intervals. Steady-state flux rose from 0.85 ± 0.68 to 8.46 ± 2.51 µg/cm2/h for olmesartan medoxomil and from 0.18 ± 0.17 to 10.06 ± 3.63 µg/cm2/h for apigenin. Conclusions: A constrained mixture design identified a SNEDDS composition that accommodated both drugs and markedly increased their transport across excised nasal mucosa relative to a suspension. These findings establish a formulation basis for the intranasal administration of this drug combination.
Source: Pharmaceutics
Authors: Ehab M. Elzayat(Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing), Sultan Almutairy(Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft), Abdelrahman Y. Sherif(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing), Mohamed M. Badran(Data curation, Formal analysis, Investigation, Methodology, Resources, Validation, Visualization, Writing – review & editing), Mohammad A. Altamimi(Formal analysis, Funding acquisition, Investigation, Resources, Writing – original draft, Writing – review & editing)
Institution: King Saud University
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
Funder: King Saud University
OpenAlex ID: W7236036510
